Skip to main navigation
Kalaris Therapeutics
  • About Us
  • Our Science
  • Leadership Team
  • Contact
  • Investors & Press

SEC Filing Details

  • Overview
  • Press Releases
  • Events & Presentations
  • SEC Filings & Tax Forms
  • Stock Information
  • Analyst Coverage
  • Corporate Governance
  • Email Alerts

Investor Contacts

ir@kalaristx.com



Media Contacts

media@kalaristx.com

Document Details

Form
SCHEDULE 13D/A
Filing Date
May 22, 2026
Document Date
May 22, 2026
Form Description
SCHEDULE 13D/A - Description
Filing Group
Other
Company
Kalaris Therapeutics
Issuer
KALARIS THERAPEUTICS, INC.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS
© Kalaris Therapeutics 2026. All rights reserved.